|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn643837425 |
003 |
OCoLC |
005 |
20231117033149.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100626s1978 nyua ob 101 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCQ
|d OCLCF
|d OCLCO
|d N$T
|d E7B
|d EBLCP
|d HEBIS
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d YDXCP
|d OCLCQ
|d MERUC
|d OCLCO
|d OCLCQ
|d STF
|d OCLCO
|d OCLCA
|d UKAHL
|d OCLCQ
|d VLY
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 608813955
|a 896795282
|a 974619825
|a 974670812
|a 1100952403
|a 1153472156
|a 1162062036
|
020 |
|
|
|a 9781483146065
|q (electronic bk.)
|
020 |
|
|
|a 1483146065
|q (electronic bk.)
|
020 |
|
|
|z 0080219381
|
020 |
|
|
|z 9780080219387
|
035 |
|
|
|a (OCoLC)643837425
|z (OCoLC)608813955
|z (OCoLC)896795282
|z (OCoLC)974619825
|z (OCoLC)974670812
|z (OCoLC)1100952403
|z (OCoLC)1153472156
|z (OCoLC)1162062036
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM315
|b .P754 1978
|
060 |
|
4 |
|a QV 77.7
|b P974 1976
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.7883
|2 18
|
245 |
0 |
4 |
|a The psychopharmacology of hallucinogens /
|c editors, Richard C. Stillman, Robert E. Willette.
|
260 |
|
|
|a New York :
|b Pergamon Press,
|c �1978.
|
300 |
|
|
|a 1 online resource (vii, 338 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; The Psychopharmacology of Hallucinogens; Copyright Page; Table of Contents; FOREWORD; CHAPTER 1. BIOSYNTHESIS AND ACTION OF HALLUCINOGENS IN MAMMALS; REFERENCES; CHAPTER 2. ROLE OF BIOGENIC AMINES IN THE ACTIONS OF MONOMETHOXY-AMPHETAMINES; INTRODUCTION; ACKNOWLEDGEMENTS; REFERENCES; CHAPTER 3. ON THE MOLECULAR MECHANISM OF ACTION OF HALLUCINOGENS; INTRODUCTION; REFERENCES; CHAPTER 4. MOLECULAR DETERMINANTS FOR INTERACTION WITH THE LSD RECEPTOR: BIOLOGICAL STUDIES AND QUANTUM CHEMICAL ANALYSIS; Biological Studies; Quantitative Structure-Activity Studies; Molecular Reactivity.
|
505 |
8 |
|
|a Simulation of the Molecular Polarization ComplexesSUMMARY; Acknowledgments; REFERENCES; Chapter 5. Progress Toward the Development of a Receptor Model for Hallucinogenic Amphetamines; INTRODUCTION; SUMMARY; REFERENCES; CHAPTER 6. CHARACTERIZATION OF THREE NEW PSYCHOTOMIMETICS; INTRODUCTION; REFERENCES; CHAPTER 7. PHARMACOLOGICAL EFFECTS OF (")-, (S)-, and (R)-MDA; METHODS; RESULTS AND DISCUSSION; REFERENCES; CHAPTER 8. SOME ASPECTS OF THE PHARMACOLOGY OF PHENCYCLIDINE; ABSTRACT; INTRODUCTION; METHODS; RESULTS; DISCUSSION; ACKNOWLEDGEMENTS; REFERENCES.
|
505 |
8 |
|
|a CHAPTER 9. THE MODE OF ACTION OF LSD-LIKE HALLUCINOGENS AND THEIR IDENTIFICATIONMETHODS; RESULTS; DISCUSSION; REFERENCES; CHAPTER 10. PRECLINICAL IDENTIFICATION OF HALLUCINOGENIC COMPOUNDS; INTRODUCTION; TEST SELECTION; LABORATORY RESEARCH; VALIDATION TESTS; DISCUSSION AND CONCLUSIONS; REFERENCES; LIST OF ABBREVIATIONS; CHAPTER 11. DUAL EFFECTS OF LSD, MESCAL INE AND DMT; Effects on Humans; Proposed Model; Facilitative vs Disruptive Effects; Effects of Monoamine Manipulations; Summary and Conclusions; ACKNOWLEDGMENTS; REFERENCES.
|
505 |
8 |
|
|a CHAPTER 12. USE OF UNCONDITIONED AND CONDITIONED BEHAVIORS IN EVALUATING POSSIBLE HALLUCINOGENIC AGENTSAbstract; Unconditioned Behavioral Studies in Mice and Rats; Conditional Behavioral Studies in Rats; Summary and Conclusions; Acknowledgements; References; CHAPTER 13. ANALYSIS OF HALLUCINOGENS BY MEANS OF PAVLOVIAN CONDITIONING; INTRODUCTION; Characteristics of Pavlovian Conditioning; Model Classical Conditioning Preparations; The Effect of LSD on Acquisition of the Rabbit Nictitating Membrane Response; Experiment 1; Experiment 2; Experiment 3; REFERENCES.
|
505 |
8 |
|
|a CHAPTER 14. AN ANIMAL BEHAVIOR MODEL FOR STUDYING THE ACTIONS OF LSD AND RELATED HALLUCINOGENSIntroduction; Method; Results; Discussion; Conclusion; Acknowledgements; References; CHAPTER 15. BEHAVIORAL MEASURES OF HALLUCINOGENIC BEHAVIOR; INTRODUCTION; REFERENCES; CHAPTER 16. ANIMAL MODELS OF DRUG-INDUCED HALLUCINATIONS; Introduction; Analogue or Assay Models; Criteria for an Animal Model of Hallucinations; The Early State of the Art; Conclusion; References; CHAPTER 17. HALLUCINOGENS AND ATTENTIONAL DYSFUNCTION: A MODEL FOR DRUG EFFECTS AND REALITY TESTING; Animal Observations; Human Reports.
|
520 |
|
|
|a The Psychopharmacology of Hallucinogens focuses on the properties, compositions, functions, transformations, and reactions of hallucinogens. The selection first offers information on the biosynthesis and action of hallucinogens in mammals; role of biogenic amines in the actions of monomethoxy-amphetamines; and molecular mechanism of action of hallucinogens. The book then takes a look at the molecular determinants for interaction with the LSD receptor, including biological studies, molecular reactivity, and summation of the molecular polarization complexes. The text examines the progress on the.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Hallucinogenic drugs
|v Congresses.
|
650 |
|
0 |
|a Psychopharmacology
|v Congresses.
|
650 |
|
0 |
|a Pharmacology, Experimental
|v Congresses.
|
650 |
|
0 |
|a Hallucinogenic drugs
|x Congresses.
|
650 |
|
0 |
|a Psychopharmacology
|x Congresses.
|
650 |
|
0 |
|a Pharmacology, Experimental
|x Congresses.
|
650 |
|
2 |
|a Behavior
|x drug effects
|0 (DNLM)D001519Q000187
|
650 |
|
2 |
|a Hallucinogens
|x pharmacology
|0 (DNLM)D006213Q000494
|
650 |
|
6 |
|a Hallucinog�enes
|0 (CaQQLa)201-0004705
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Psychopharmacologie
|0 (CaQQLa)201-0020955
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Pharmacologie exp�erimentale
|0 (CaQQLa)201-0089582
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Hallucinog�enes
|0 (CaQQLa)201-0004705
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Psychopharmacologie
|0 (CaQQLa)201-0020955
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Pharmacologie exp�erimentale
|0 (CaQQLa)201-0089582
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Hallucinogenic drugs
|2 fast
|0 (OCoLC)fst00950651
|
650 |
|
7 |
|a Pharmacology, Experimental
|2 fast
|0 (OCoLC)fst01060280
|
650 |
|
7 |
|a Psychopharmacology
|2 fast
|0 (OCoLC)fst01081659
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Stillman, Richard C.
|
700 |
1 |
|
|a Willette, Robert E.
|
710 |
2 |
|
|a National Institute on Drug Abuse.
|b Division of Research.
|
776 |
0 |
8 |
|i Print version:
|t Psychopharmacology of hallucinogens.
|d New York : Pergamon Press, �1978
|w (DLC) 78014019
|w (OCoLC)4496008
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080219387
|z Texto completo
|